Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

FRACTALKINE GENE RECEPTOR POLYMORPHISM IN PATIENTS WITH MULTIPLE SCLEROSIS.
Improving Safety and Operational Efficiency in Residential Care Settings With WiFi-Based Localization.
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A.
Multiple sclerosis: RBPJ identified as an autoantigen in multiple sclerosis.
Cerebral white matter disease in patients with malignancy: pml versus toxic leucoencephalopathy due to chemotherapy.
[Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)].
Psychiatric disorders revealing multiple sclerosis after 20 years of evolvement.
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
Accuracy of a custom physical activity and knee angle measurement sensor system for patients with neuromuscular disorders and gait abnormalities.
Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis.
[Vitamin D and multiple sclerosis].
Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study.
[Kidney function tests in multiple sclerosis].
Thermal and motor behavior in experimental autoimmune encephalitis in Lewis rats.
In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis.
The use of telemedicine in patients with multiple sclerosis.
Moving to Fingolimod From Natalizumab in Multiple Sclerosis: The ENIGM Is Not Solved.
[A different approach to the care of patients with MS].
Isolated Brain Stem Lesion in Children: Is It Acute Disseminated Encephalomyelitis or Not?
Prolactin in multiple sclerosis.
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients.
Bipolar disorder and multiple sclerosis: A case series.
Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.

Pages